[{"uuid": "24ab4a41-921b-32fa-b785-d9237546e085", "title": "Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week", "publisher": "Investopedia", "link": "https://finance.yahoo.com/m/24ab4a41-921b-32fa-b785-d9237546e085/watch-these-grail-price.html", "providerPublishTime": 1737951173, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/tPzSb81mX44QGVAKMlLQlQ--~B/aD03MDg7dz0xNzcwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/investopedia_245/c1d645f84d5c2e4952e48477f7d5e8ce", "width": 1770, "height": 708, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/DMNw3bsgoZOeuNc7p0JErA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/investopedia_245/c1d645f84d5c2e4952e48477f7d5e8ce", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL"]}, {"uuid": "e7c90e26-b338-3fae-87ad-1c17e6fc4523", "title": "Why Grail (GRAL) Is Rallying for a Second Straight Day", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-grail-gral-rallying-second-174201352.html", "providerPublishTime": 1737654121, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/6aG2bEZMrkyrqVq9ZZWhmw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e05b75d5dfcd453388f4bf7f54856ef5", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/NwPULUbuWapaW2JV78JzWg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e05b75d5dfcd453388f4bf7f54856ef5", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL"]}, {"uuid": "4ee0b747-6d73-3b2e-b0c2-6dc101f75df9", "title": "Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20%", "publisher": "Investopedia", "link": "https://finance.yahoo.com/m/4ee0b747-6d73-3b2e-b0c2-6dc101f75df9/early-cancer-detection-firm.html", "providerPublishTime": 1737566483, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/bZsDZixSX3TyG8XVsLf4xw--~B/aD0xNzA3O3c9MjU2MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/investopedia_245/54fc9d0b64f6a60fd9d20556c4fdd61d", "width": 2560, "height": 1707, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/kqqibKPd.jyXVQX02x2HsQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/investopedia_245/54fc9d0b64f6a60fd9d20556c4fdd61d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL", "ILMN"]}, {"uuid": "e52cd224-f173-382a-b9b3-e3d0375e5d64", "title": "Grail's 2024 Revenue Guidance Beats Analyst Estimates", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/grail-apos-2024-revenue-guidance-175744829.html", "providerPublishTime": 1736963864, "type": "STORY", "relatedTickers": ["GRAL"]}, {"uuid": "2a0ba250-91a5-3749-9abf-15303ea17b51", "title": "Patient Reported Outcomes for GRAIL's Galleri\u00ae Multi-Cancer Early Detection Blood Test Published in Lancet Oncology", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/patient-reported-outcomes-grails-galleri-234900247.html", "providerPublishTime": 1736812140, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H0W_YR0aAlLQ9_M4J5MNSg--~B/aD03Njt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 400, "height": 76, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TyvPGpxMuts4f8R9D4kAEQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL"]}, {"uuid": "b4ea6e30-1b21-3664-aca2-b30c33c6210a", "title": "Equity Markets Post Double-Digit Gains for 2024", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/equity-markets-post-double-digit-215512781.html", "providerPublishTime": 1735682112, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_8ROLj_eGdOJIxXAZcVMog--~B/aD03Njg7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a", "width": 1024, "height": 768, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/E4TzOW1lc8PhY5tQFinAUA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["COMP", "SPGI", "^DJI"]}, {"uuid": "fbf95293-c1c6-3cf4-93d4-851da1e6274e", "title": "Equity Markets Fall Intraday as 2024 Draws to Close", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/equity-markets-fall-intraday-2024-185854220.html", "providerPublishTime": 1735671534, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_8ROLj_eGdOJIxXAZcVMog--~B/aD03Njg7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a", "width": 1024, "height": 768, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/E4TzOW1lc8PhY5tQFinAUA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/0c887a492733aab96ac405a5871f559a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["COMP", "^DJI", "SPGI"]}, {"uuid": "84dc2366-9402-35cf-a59a-33a22c8d3292", "title": "Disappointing week for GRAIL, Inc. (NASDAQ:GRAL) institutional investors who control 48% of the company", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/disappointing-week-grail-inc-nasdaq-110220949.html", "providerPublishTime": 1735124540, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dQxIoNx1LKM.kOJYTi633A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL"]}, {"uuid": "cf461e7b-aa91-371d-890d-de4d965822fe", "title": "GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/grail-present-43rd-annual-j-210100205.html", "providerPublishTime": 1734555660, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H0W_YR0aAlLQ9_M4J5MNSg--~B/aD03Njt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 400, "height": 76, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TyvPGpxMuts4f8R9D4kAEQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL"]}, {"uuid": "0e8b9883-57e0-3f7b-bb93-f640cf900628", "title": "Grail 1st-Mover Advantage Faces Regulatory Hurdles in Multi-Cancer Detection, Morgan Stanley Says", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/grail-1st-mover-advantage-faces-162142045.html", "providerPublishTime": 1732724502, "type": "STORY", "relatedTickers": ["GRAL"]}, {"uuid": "e2232e5c-4ea6-3aee-b5d5-0db101c58214", "title": "GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/grail-announces-inducement-grants-under-210100478.html", "providerPublishTime": 1733259660, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H0W_YR0aAlLQ9_M4J5MNSg--~B/aD03Njt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 400, "height": 76, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TyvPGpxMuts4f8R9D4kAEQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL"]}, {"uuid": "610d5459-b53b-3df6-9cdc-8def41f6aa33", "title": "GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/grail-announces-first-patient-tested-210100573.html", "providerPublishTime": 1731963660, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H0W_YR0aAlLQ9_M4J5MNSg--~B/aD03Njt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 400, "height": 76, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TyvPGpxMuts4f8R9D4kAEQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DSKYF", "DSNKY", "GRAL", "AZN", "AZNCF"]}, {"uuid": "9ff5dc99-3a43-321e-84c4-916afc2d5dd6", "title": "What's Going On With Illumina Stock On Monday?", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/whats-going-illumina-stock-monday-184318792.html", "providerPublishTime": 1734374598, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qWGonvSw1cqQT0T_3m3KYA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/046a24a7cbd2d7f553f926bbe507bcc6", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/697okddgUpAjFTGw4_oGaw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/046a24a7cbd2d7f553f926bbe507bcc6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ILMN", "GRAL"]}, {"uuid": "2f2b47dc-404f-3868-9821-1350c6782228", "title": "GRAIL Reports Third Quarter 2024 Financial Results", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/grail-reports-third-quarter-2024-210600903.html", "providerPublishTime": 1731445560, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H0W_YR0aAlLQ9_M4J5MNSg--~B/aD03Njt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 400, "height": 76, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TyvPGpxMuts4f8R9D4kAEQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL"]}, {"uuid": "6a5c6d0a-796a-3bb2-93f5-2bd36fd04850", "title": "EU Approves Nvidia\u2019s Run:ai Takeover", "publisher": "The Wall Street Journal", "link": "https://finance.yahoo.com/m/6a5c6d0a-796a-3bb2-93f5-2bd36fd04850/eu-approves-nvidia%E2%80%99s-run%3Aai.html", "providerPublishTime": 1734698640, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Fwf5HL4GsEGPbDfR3MJBPg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8", "width": 1200, "height": 630, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/zIJaagDuCJitt1Cvcwyc7A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL.MI", "NVDA", "ILMN"]}, {"uuid": "aa53ec09-323e-36df-9785-830c113b6e4a", "title": "GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/grail-inc-gral-q3-2024-190025553.html", "providerPublishTime": 1731610825, "type": "STORY", "relatedTickers": ["GRAL"]}, {"uuid": "e7374a5e-e6ed-3552-87b6-223599016ff2", "title": "GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/grail-third-quarter-2024-earnings-101337429.html", "providerPublishTime": 1731579217, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 945, "height": 636, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/NamfX5LEtyScIu4YmRG2hg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL"]}, {"uuid": "1f23e0fb-5ca0-3b14-9c03-508dc05ad51b", "title": "GRAIL to Participate in Upcoming Investor Conferences", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/grail-participate-upcoming-investor-conferences-210500920.html", "providerPublishTime": 1732050300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/H0W_YR0aAlLQ9_M4J5MNSg--~B/aD03Njt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 400, "height": 76, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TyvPGpxMuts4f8R9D4kAEQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/df6f1c041e7249704f56bfd0aaad45cf", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRAL"]}, {"uuid": "27739922-8036-3850-b1bd-8010b16f8e20", "title": "GRAIL Says First Person Tested With Blood-Based Assay in Lung Cancer Trial", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/grail-says-first-person-tested-221001534.html", "providerPublishTime": 1731967801, "type": "STORY", "relatedTickers": ["GRAL"]}, {"uuid": "fb14d8be-af65-34b9-9970-388f6c1226e8", "title": "One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's", "publisher": "Investor's Business Daily", "link": "https://finance.yahoo.com/m/fb14d8be-af65-34b9-9970-388f6c1226e8/one-of-ibd%27s-best-screens.html", "providerPublishTime": 1733860338, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/LULNv6y6vHDPF2ZCPGcuYA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/1b656195b8e1d11a783c5bd1d0c94472", "width": 1000, "height": 563, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/5xOr.aYTeVPBLWpX_ikkBg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/1b656195b8e1d11a783c5bd1d0c94472", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GRMN", "AOSL", "OLLI", "GRAL"]}]